World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
49
Citations
9463
World Ranking
5954
National Ranking
2610

Overview

David Feifel is affiliated with the University of California, San Diego in the United States. Their research spans multiple fields, primarily focusing on psychology, medicine, and neuroscience. Within these areas, Feifel has contributed notably to subfields including neurology, social psychology, clinical psychology, experimental and cognitive psychology, and organic chemistry.

Feifel's work centers on several main topics, such as neuroendocrine regulation and behavior, transcranial magnetic stimulation studies, evolutionary psychology and human behavior, psychedelics and drug studies, chemical synthesis and alkaloids, treatment of major depression, and functional brain connectivity studies.

Key recent papers authored or coauthored by Feifel include:

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022, New England Journal of Medicine)
  • Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial (2021, World Psychiatry)
  • Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life (2023, Journal of Affective Disorders)
  • Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication (2023, Neuropsychopharmacology)
  • Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial (2021, Biological Psychiatry)

Frequent coauthors collaborating with Feifel include Tian Lin, Natalie C. Ebner, Guy M. Goodwin, Boadie W. Dunlop, and David J. Hellerstein.

The preferred publication venues for Feifel's research include:

  • Journal of Affective Disorders
  • Brain Stimulation
  • Biological Psychiatry
  • New England Journal of Medicine
  • World Psychiatry

Best Publications

  • Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.

    Unknown

  • A systematic review of modafinil: Potential clinical uses and mechanisms of action.

    Jacob S. Ballon;David Feifel

  • Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial.

    Lior Carmi;Aron Tendler;Alexander Bystritsky;Eric Hollander

  • Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

    David Feifel;Kai Macdonald;Angel Nguyen;Patrice Cobb

  • Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania

    William Perry;Arpi Minassian;Arpi Minassian;David Feifel;David L Braff

  • Attitudes Toward Psychiatry as a Prospective Career Among Students Entering Medical School

    David Feifel;Christine Yu Moutier;Neal R. Swerdlow

  • Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial

    Abraham Zangen;Hagar Moshe;Diana Martinez;Noam Barnea-Ygael

  • Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders

    Kai Macdonald;David Feifel

  • Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.

    Glenn W. Currier;James C.-Y. Chou;David Feifel;Cynthia A. Bossie

  • Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.

    Michael D. Lesem;Tram K. Tran-Johnson;Robert A. Riesenberg;David Feifel

  • Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study.

    Andrew J. Cutler;Stuart A. Montgomery;David Feifel;Arthur Lazarus

  • Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression.

    Kai MacDonald;Tina Marie MacDonald;Martin Brüne;Kristi Lamb

  • The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample.

    Dean T. Acheson;David Feifel;Sofieke de Wilde;Rebecca Mckinney

  • Oxytocin's role in anxiety: a critical appraisal.

    Kai MacDonald;David Feifel

  • Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating.

    D. Feifel;Tammi Reza

  • Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.

    David Feifel;Kai MacDonald;Patrice Cobb;Arpi Minassian

  • Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

    Unknown

  • Oxytocin in schizophrenia: a review of evidence for its therapeutic effects

    Kai MacDonald;David Feifel

  • Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression

    Andrew F. Leuchter;Ian A. Cook;David Feifel;John W. Goethe

  • Inhibitory deficits in ocular motor behavior in adults with attention-deficit/hyperactivity disorder

    David Feifel;Robert H. Farber;Brett A. Clementz;William Perry

  • Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

    Michael H. Allen;David Feifel;Michael D. Lesem;Daniel L. Zimbroff

  • Novel Antipsychotic-Like Effects on Prepulse Inhibition of Startle Produced by a Neurotensin Agonist

    David Feifel;Tammi L. Reza;David J. Wustrow;M. Duff Davis

  • A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia

    David Feifel;Paul D. Shilling;Kai MacDonald

  • ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS

    David Feifel

Frequent Co-Authors

William Perry
William Perry University of California, San Diego
Håkan Fischer
Håkan Fischer Stockholm University
Mark S. George
Mark S. George Medical University of South Carolina
Neal R. Swerdlow
Neal R. Swerdlow University of California, San Diego
Ronald A. Cohen
Ronald A. Cohen University of Florida
Abraham Zangen
Abraham Zangen Ben-Gurion University of the Negev
Victoria B. Risbrough
Victoria B. Risbrough University of California, San Diego
Daniel Z. Press
Daniel Z. Press Harvard Medical School
Yvette I. Sheline
Yvette I. Sheline University of Pennsylvania
Michael E. Thase
Michael E. Thase University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A degree in neuroscience opens doors to various career paths beyond traditional research. Many students interested in brain science, mental health, or counseling choose to expand their qualifications through related online degrees. If you are passionate about therapy and family dynamics, consider marriage and family therapy master's programs. These programs focus on supporting families and couples, and can lead to licensed clinical work.

Those curious about broader aspects of behavior and mental processes may explore online psychology masters or entry-level psychology degrees. Psychology is a versatile field that covers topics from cognitive science to organizational behavior and offers diverse career options in counseling, education, or business.

Additionally, if your interests lie in social impact and community work, an online master's in social work may be valuable. This degree prepares graduates for roles in advocacy, case management, and therapy, complementing neuroscience expertise with practical skills to help individuals navigate life challenges. Choosing the right pathway can enhance your career and make a meaningful difference in various settings.

Best Scientists Citing David Feifel

Trending Scientists

Recently Published Articles